Mycobacterium tuberculosis co-infection is associated with increased surrogate marker of the HIV reservoirJingna Xun, Hongzhou Lu, Tangkai Qi et al.|AIDS Research and Therapy|2020Cited by 22
Trends in and Risk Factors for Drug Resistance in Mycobacterium tuberculosis in HIV-Infected PatientsXiaoqin Le, Yinzhong Shen, Xueqin Qian et al.|Viruses|2024Cited by 8
Prevalence and associated factors of low bone mineral density in people living with HIV: a cross-sectional studyYueming Shao, Jun Chen, Zhenyan Wang et al.|Archives of Osteoporosis|2024Cited by 7
Pharmacokinetic features of dolutegravir with rifampicin and rifabutin among patients coinfected with human immunodeficiency virus and tuberculosis/mycobacterium avium complexXiaoqin Le, Jun Chen, Xiaoye Guo et al.|International Journal of Infectious Diseases|2022Cited by 6
Bone Mineral Density Changes in People with HIV Who had Immediate Switch Versus Deferred Switch from Tenofovir Disoproxil Fumarate-Based Regimens to Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Multicenter, Open-Label, Randomized Clinical TrialYueming Shao, Jun Chen, Xinping Yang et al.|Infectious Diseases and Therapy|2025Cited by 2